RAYMOND JAMES & ASSOCIATES - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$164,000
-45.2%
27,216
-73.4%
0.00%
Q3 2019$299,000
+63.4%
102,400
+49.7%
0.00%
Q2 2019$183,000
-17.9%
68,415
-9.3%
0.00%
Q1 2019$223,000
+95.6%
75,415
+5.5%
0.00%
Q4 2018$114,000
-51.7%
71,450
+11.6%
0.00%
Q3 2018$236,000
+32.6%
64,050
+1.6%
0.00%
Q2 2018$178,000
-23.6%
63,050
+0.3%
0.00%
Q1 2018$233,000
+18.3%
62,850
-8.2%
0.00%
Q4 2017$197,000
-49.9%
68,450
-21.7%
0.00%
-100.0%
Q3 2017$393,000
-14.0%
87,450
-12.2%
0.00%0.0%
Q2 2017$457,000
+11.5%
99,565
+2.2%
0.00%0.0%
Q1 2017$410,000
-3.5%
97,465
-5.3%
0.00%0.0%
Q4 2016$425,000
-53.1%
102,965
-8.0%
0.00%
-50.0%
Q3 2016$907,000
+10.5%
111,965
-23.3%
0.00%
-33.3%
Q2 2016$821,000
+7.5%
145,981
+47.5%
0.00%0.0%
Q1 2016$764,000
-40.4%
99,000
-16.6%
0.00%
-40.0%
Q4 2015$1,281,000
+65.3%
118,702
+5.8%
0.01%
+66.7%
Q3 2015$775,000
-27.2%
112,150
-6.7%
0.00%
-25.0%
Q2 2015$1,065,000
-12.0%
120,223
-2.0%
0.00%
-20.0%
Q1 2015$1,210,000
+5.2%
122,700
+30.7%
0.01%
-16.7%
Q4 2014$1,150,000
+122.9%
93,907
+81.6%
0.01%
+100.0%
Q3 2014$516,000
-3.2%
51,700
-26.6%
0.00%0.0%
Q2 2014$533,000
+11.0%
70,400
-51.8%
0.00%0.0%
Q1 2014$480,000146,0000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders